The relationship being tested is that regurgitant volume per beat in mitral regurgitation equals the product of the effective regurgitant orifice area and the velocity-time integral of the MR jet. EROA represents the size of the leak, while VTI_MR is the distance that blood travels during the regurgitant jet in one heartbeat, obtained by integrating the MR jet velocity over time. Multiplying these gives the total volume of blood regurgitated per beat: EROA × VTI_MR, and the units work out to milliliters. This also makes intuitive sense: a larger orifice lets more blood flow per unit time, and a longer duration of regurgitation (captured by a larger VTI_MR) increases the total amount of regurgitated blood. If you divided EROA by VTI_MR or added them, the units wouldn’t yield a volume, and saying regurgitant volume is independent of EROA contradicts the physics of flow across an orifice.

The LVOT and aortic root are best visualized when the ultrasound beam is aligned with the long axis of the left ventricle and the aorta. In the parasternal long-axis view, the transducer sits at the left sternal border and the imaging plane runs from the left atrium through the mitral valve, into the left ventricle, and then along the LV outflow tract into the aortic valve and proximal aorta. This single plane shows the LVOT as it feeds the aortic root, allowing clear assessment of both structures and their relationship, as well as easy measurements of the LVOT diameter and evaluation of the proximal aorta. Other views don’t provide this same longitudinal alignment. The apical four-chamber view emphasizes the chambers and valves in a cross-sectional orientation and offers limited visualization of the LVOT and aortic root in a continuous, aligned path. The parasternal short-axis view SAMPLEslices across the outflow tract, giving a cross-section rather than a longitudinal view of the LVOT and proximal aorta, which can obscure their relationship. The subcostal view is useful in certain patients or for specific questions but generally does not optimize visualization of the LVOT and aortic root in a single, consistent plane.

Contrast-enhanced echocardiography goes beyond simply making borders clearer by using microbubble contrast to illuminate the chambers. This is especially valuable when the acoustic window is poor, because the contrast makes the endocardial borders much easier to see, which improves the reliability of assessing chamber size and wall motion. More importantly, it helps reveal pathology that grayscale imaging can miss: intraventricular thrombus, particularly in the LV apex, appears as a filling defect against an opacified cavity, making thrombus much easier to detect. It also enables detection of small intracardiac or intrapulmonary shunts by showing bubble transit from the right side to the left side of the circulation, which can be missed on unenhanced studies. All of these benefits contribute to higher diagnostic confidence in challenging studies. It’s not intended to replace all other imaging or rely solely on contrast; other imaging modalities and clinical information remain important when indicated.

Standardizing LV mass for body size allows meaningful comparisons between people. LV mass tends to be larger in bigger individuals simply because their hearts scale with overall body size. By indexing LV mass to body surface area, we adjust for that size difference, so a LV mass can be judged as proportionate or disproportionate to the person’s body, revealing true hypertrophy rather than normal variation. This makes cross-person comparisons more accurate and helps identify pathological hypertrophy across different ages, sexes, and body types. The other options don’t capture this normalization purpose, as indexing isn’t primarily about simplifying calculations or assessing systolic function or diastolic pressures.